Home > Healthcare > Pharmaceuticals > Finished Drug Form > Benzodiazepine Drugs Market

Benzodiazepine Drugs Market Share

Report ID: GMI8454
Published Date: Mar 2024
Report Format: PDF

Download Free Sample

Benzodiazepine Drugs Market Share

The competitive landscape of the benzodiazepine drugs industry is characterized by the presence of established pharmaceutical companies vying for market share. Novartis AG, GlaxoSmithKline plc, Pfizer Inc., and Roche account for significant market share. These prominent players adopt a combination of strategic initiatives such as collaboration & partnership, global expansion, research and development, product diversification, and regulatory compliance to maintain a competitive edge in the market.

Benzodiazepine Drugs Market Companies

Prominent players operating in the benzodiazepine drugs industry are as mentioned below:

AbbVie Inc.
Amneal Pharmaceuticals LLC.
Bausch Health Companies Inc.
Boehringer Ingelheim International GmbH
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline Plc.
Hikma Pharmaceuticals PLC
Mylan N.V.
Novartis AG
Pfizer Inc.
Sanofi
Teva Pharmaceutical Industries Ltd.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Benzodiazepine drugs market size was USD 2.8 billion in 2023 and is expected to register 3.9% CAGR from 2024-2032 owing to the increasing prevalence of anxiety disorders and insomnia worldwide.

The alprazolam segment recorded USD 836.1 million in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to its high efficacy in treating anxiety disorders, panic disorders, and various other conditions.

North America benzodiazepine drugs industry is expected to reach USD 1.6 billion by 2032 due to high prevalence of anxiety disorders and other related conditions along with well-established pharmaceutical industry and favorable regulatory environment in the region.

Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc., Hikma Pharmaceuticals PLC, Mylan N.V., Novartis AG, Pfizer Inc., Sanofi, and Teva Pharmaceutical Industries Ltd., are some of the major benzodiazepine drugs companies worldwide.